Scout Investments Inc. Raises Position in Teleflex Incorporated (NYSE:TFX)

Scout Investments Inc. boosted its holdings in Teleflex Incorporated (NYSE:TFX) by 41.9% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 64,622 shares of the medical technology company’s stock after purchasing an additional 19,076 shares during the period. Scout Investments Inc. owned about 0.14% of Teleflex worth $24,333,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Highlander Capital Management LLC acquired a new stake in Teleflex in the 2nd quarter valued at approximately $40,000. Group One Trading L.P. purchased a new stake in shares of Teleflex during the second quarter worth $40,000. Evolution Wealth Advisors LLC raised its holdings in Teleflex by 60.3% during the second quarter. Evolution Wealth Advisors LLC now owns 109 shares of the medical technology company’s stock valued at $44,000 after buying an additional 41 shares in the last quarter. Berman Capital Advisors LLC raised its holdings in Teleflex by 210.5% during the second quarter. Berman Capital Advisors LLC now owns 118 shares of the medical technology company’s stock valued at $47,000 after buying an additional 80 shares in the last quarter. Finally, Cullen Frost Bankers Inc. acquired a new stake in shares of Teleflex in the second quarter valued at about $68,000. 94.65% of the stock is owned by hedge funds and other institutional investors.

A number of research firms recently weighed in on TFX. Zacks Investment Research downgraded Teleflex from a “hold” rating to a “sell” rating and set a $396.00 target price on the stock. in a research report on Tuesday, October 26th. SVB Leerink lifted their price objective on Teleflex from $410.00 to $415.00 and gave the company a “market perform” rating in a report on Friday, July 30th. JMP Securities decreased their price objective on Teleflex from $470.00 to $430.00 and set a “market outperform” rating on the stock in a report on Friday, October 29th. Raymond James decreased their price objective on Teleflex from $440.00 to $391.00 and set an “outperform” rating on the stock in a report on Friday, October 29th. Finally, KeyCorp cut their target price on shares of Teleflex from $448.00 to $439.00 and set an “overweight” rating for the company in a research note on Monday, August 2nd. One research analyst has rated the stock with a sell rating, one has given a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, Teleflex presently has a consensus rating of “Buy” and a consensus target price of $440.73.

In other Teleflex news, VP Cameron P. Hicks sold 3,600 shares of the company’s stock in a transaction on Wednesday, November 10th. The shares were sold at an average price of $350.00, for a total transaction of $1,260,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.34% of the company’s stock.

TFX stock opened at $317.77 on Thursday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.74 and a quick ratio of 1.88. The company has a 50 day moving average price of $361.03 and a 200 day moving average price of $382.53. Teleflex Incorporated has a fifty-two week low of $312.68 and a fifty-two week high of $449.38. The stock has a market capitalization of $14.89 billion, a PE ratio of 34.73 and a beta of 1.08.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, October 28th. The medical technology company reported $3.51 earnings per share for the quarter, topping the consensus estimate of $3.03 by $0.48. Teleflex had a net margin of 15.71% and a return on equity of 17.78%. The firm had revenue of $700.25 million during the quarter, compared to analysts’ expectations of $698.25 million. During the same quarter in the previous year, the company posted $2.77 EPS. Teleflex’s revenue was up 11.5% on a year-over-year basis. As a group, equities analysts expect that Teleflex Incorporated will post 13.26 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 15th. Investors of record on Monday, November 15th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.43%. The ex-dividend date is Friday, November 12th. Teleflex’s dividend payout ratio (DPR) is presently 14.86%.

Teleflex Company Profile

Teleflex, Inc provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.

Featured Article: Lock-Up Period Expiration

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.